Description
A MIF inhibitor; decreases skin thickness and MPO activity and induces keratinocyte apoptosis, as well as reduces papilloma formation and progression to micro-invasive SCC in a mouse model of UVB-induced SCC at 20 mg/kg per day; lowers blood glucose levels and serum levels of IL-6 and TNF-α in a mouse model of streptozotocin-induced NIDDM
Formal name: 2-[3-(2,4-difluorophenyl)-4,5-dihydro-5-isoxazolyl]-1-(4-morpholinyl)-ethanone
Synonyms:
Molecular weight: 310.3
CAS: 1309793-47-2
Purity: ≥95%
Formulation: A crystalline solid